Kuopio University Hospital
Kuopio, 70211, Finland
NCT Number: NCT00854321
One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kuopio, 70211, Finland
Data is collected on regular visits in the outpatient department. In collection national register forms have been used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
rituximab two 1000 mg intravenous infusions separated by two weeks
two 1000 mg intravenous infusions separated by 2 weeks
Time frame: 6 and 12 months
Time frame: 6 and 12 months
Kuopio University Hospital
Other
One Centre Follow-up Study on Safety and Efficacy
Acronym: KuoRituxi1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03649178
Arthritis, Arthritis, Rheumatoid
Nashville, Tennessee, United States
View Trial DetailsNCT03025308
Arthritis, Arthritis, Rheumatoid
Huntsville, Alabama, United States
View Trial DetailsNCT07715045
Arthritis, Arthritis, Rheumatoid
Palembang, South Sumatera, Indonesia
View Trial DetailsNCT00055055
Arthritis, Arthritis, Rheumatoid
Bethesda, Maryland, United States
View Trial Details